ARTICLEhttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/11/article-p1366.xmlPatterns of Chemotherapy Administration in High-Risk Soft Tissue Sarcoma and Impact on Overall Survival2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/11/article-p1366.pdf2026-04-18Patterns of Chemotherapy Administration in High-Risk Soft Tissue Sarcoma and Impact on Overall Survivalhttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/11/article-pxxxiii.xmlNCCN News2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/11/article-pxxxiii.pdf2026-04-18NCCN Newshttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/11/article-p1299.xmlMultidisciplinary Care: For the Sake of Our Patients2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/11/article-p1299.pdf2026-04-18Multidisciplinary Care: For the Sake of Our Patientshttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/11/article-p1297.xmlAt Last: Getting Paid to Think!2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/11/article-p1297.pdf2026-04-18At Last: Getting Paid to Think!https://harbor.dev.pubfactory.com/view/journals/jnccn/13/11/article-pxliv.xmlOncology Research Program2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/11/article-pxliv.pdf2026-04-18Oncology Research Programhttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/11/article-p1321.xmlUterine Sarcoma, Version 1.20162026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/11/article-p1321.pdf2026-04-18Uterine Sarcoma, Version 1.2016https://harbor.dev.pubfactory.com/view/journals/jnccn/13/11/article-p1337.xmlNCCN Oncology Research Program's Investigator Steering Committee and NCCN Best Practices Committee Molecular Profiling Surveys2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/11/article-p1337.pdf2026-04-18NCCN Oncology Research Program's Investigator Steering Committee and NCCN Best Practices Committee Molecular Profiling Surveyshttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/11/article-p1351.xmlThe Impact of Insurance Status on Tumor Characteristics and Treatment Selection in Contemporary Patients With Prostate Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/11/article-p1351.pdf2026-04-18The Impact of Insurance Status on Tumor Characteristics and Treatment Selection in Contemporary Patients With Prostate Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/11/article-p1310.xmlEwing Sarcoma in a Patient With Cowden Syndrome2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/11/article-p1310.pdf2026-04-18Ewing Sarcoma in a Patient With Cowden Syndromehttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/11/article-p1301.xmlBuying In2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/11/article-p1301.pdf2026-04-18Buying Inhttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/11/article-p1440.xmlRole of Immune Therapies for Myeloma2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/11/article-p1440.pdf2026-04-18Role of Immune Therapies for Myelomahttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/11/article-p1383.xmlDose Delays, Dose Reductions, and Relative Dose Intensity in Patients With Cancer Who Received Adjuvant or Neoadjuvant Chemotherapy in Community Oncology Practices2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/11/article-p1383.pdf2026-04-18Dose Delays, Dose Reductions, and Relative Dose Intensity in Patients With Cancer Who Received Adjuvant or Neoadjuvant Chemotherapy in Community Oncology Practiceshttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/11/article-p1398.xmlMultiple Myeloma, Version 2.20162026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/11/article-p1398.pdf2026-04-18Multiple Myeloma, Version 2.2016https://harbor.dev.pubfactory.com/view/journals/jnccn/13/11/article-p1448.xmlIs the Preoperative Setting an Appropriate Platform for Drug Approval in Breast Cancer?2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/11/article-p1448.pdf2026-04-18Is the Preoperative Setting an Appropriate Platform for Drug Approval in Breast Cancer?